Residual DNA Quantification Kit for human cell

Cell-based biopharmaceutical production systems, such as mammalian cell culture, are widely used in the production of biologics, including monoclonal antibodies, vaccines, and recombinant proteins. However, during the manufacturing process, residual host cell DNA may be inadvertently introduced into the final product. This residual DNA poses potential safety risks, including carcinogenicity and infectious risks. Therefore, regulatory agencies such as the US FDA and EMA have set strict guidelines on the permissible levels of residual DNA in biologics, requiring robust and sensitive quantitative methods.

The Human Cell Residual DNA Quantification Kit is a key tool designed to accurately measure trace amounts of human DNA in biological products. The detection principle usually relies on quantitative PCR (qPCR), leveraging its high sensitivity, specificity, and throughput capabilities to meet regulatory requirements. The application range of the Residual DNA Quantification Kit is wide and significant. It is used in various stages of the biopharmaceutical manufacturing process, including raw material evaluation, in-process monitoring, and final product testing. The kit ensures that the residual DNA level is always below the regulatory threshold, thereby ensuring product safety.